All Articles

Health tech firm Ash adds Jon Stout and Matt Benton, who scaled AbleTo to a $470M acquisition, to conquer the competitive Medicare Advantage market.

With over a million visitors across three continents, Wevr is proving location-based VR can be both culturally resonant and commercially viable. But is this the future?

Podean's sixth acquisition in nine months brings TikTok Shop leader SCC into its fold, creating a global powerhouse to master social commerce's growth.

ugee's new Funbox printer targets the family market with AI-powered design and robust safety features, challenging rivals by making STEM learning truly accessible.

As AI transforms healthcare, a complex legal maze emerges. Top law firms are now in a talent arms race, hiring former regulators to guide firms through the chaos.

As data breaches plague healthcare, ForeSee Medical's rigorous HITRUST r2 certification signals a strategic shift. Is this the new gold standard for trust?

PATRÓN and Becky G's new project promises clean water for Jalisco. Is it a new model for corporate responsibility or the future of luxury brand marketing?

Plumas Bancorp's record earnings are fueled by a major acquisition, but a spike in nonperforming assets reveals the inherent risks of rapid expansion.

With a strategic investment from Persephoni, SelSym Biotech is advancing SymClot, a synthetic blood-clotting agent that could redefine emergency medicine.

Facing a workforce crisis, health systems invest heavily in retention with little proof of impact. A new guide aims to change that, shifting from anecdote to intelligence.

Emergent's massive Series C and unicorn status signal a new frontier for SMBs. But can its "agentic AI" truly deliver production-ready software, or do hidden costs and technical risks remain?

As the energy sector grapples with volatility, S&P Global's Tier 1 ranking is becoming a crucial currency of trust. Fluence's repeat success reveals a deeper story.

SBC Medical is stepping onto the investor stage. We break down their strategy to dominate the booming wellness market, from US expansion to AI-driven healthcare.

As federal mandates push to end decades of stagnation, one company's 'truly real-time' platform offers a foundational fix for drug development.

The American Academy of Pediatrics is plugging its gold-standard guidance into an AI brain. It’s a move set to transform pediatric care and a major test for AI.

Grove and Galaxy Digital's new $500M warehouse facility isn't just a loan—it's a landmark adoption of traditional finance architecture for digital assets.

Enterprises are losing millions to complex hyperscaler deals. An advisory firm reports $65M in client savings, exposing the hidden risks and a playbook to fight back.

Joel Gott Wines, a name synonymous with quality bottled wine, is entering the RTD fray with Sauvy B. Is this a savvy diversification or a risky departure?

The James Beard Foundation is seeking a new home, sparking a high-stakes competition among US cities for a multi-million dollar economic and cultural prize.

James Bair's move from Google to Crowell & Moring shows a new trend: tech insiders are now the most valuable players in defending against DC scrutiny.